First Hawaiian Bank’s Emergent Biosolutions EBS Stock Holding History

First Hawaiian Bank’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,705	Closed	-$239K	–	851
2022 Q2	$239K	Sell	7,705 -575	-7%	-$19.6K	0.01%	778
2022 Q1	$340K	Hold	8,280	–	–	0.01%	730
2021 Q4	$360K	Sell	8,280 -272	-3%	-$12.3K	0.01%	729
2021 Q3	$428K	Hold	8,552	–	–	0.02%	571
2021 Q2	$539K	Sell	8,552 -778	-8%	-$50K	0.02%	483
2021 Q1	$867K	Hold	9,330	–	–	0.04%	337
2020 Q4	$836K	Sell	9,330 -1,588	-15%	-$146K	0.04%	325
2020 Q3	$1.13M	Sell	10,918 -774	-7%	-$83.4K	0.06%	232
2020 Q2	$925K	Sell	11,692 -1,977	-14%	-$147K	0.05%	272
2020 Q1	$791K	Buy	13,669 +1,992	+17%	+$115K	0.05%	260
2019 Q4	$630K	Sell	11,677 -934	-7%	-$50.7K	0.03%	387
2019 Q3	$659K	Sell	12,611 -31	-0.2%	-$1.44K	0.03%	366
2019 Q2	$611K	Buy	12,642 +11,248	+807%	+$539K	0.03%	385
2019 Q1	$70K	Buy	1,394 +611	+78%	+$36K	﹤0.01%	968
2018 Q4	$46K	Buy	783 +127	+19%	+$8.19K	﹤0.01%	1096
2018 Q3	$43K	Buy	+656	New	+$38.3K	﹤0.01%	1189

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Hawaiian Bank's EBS Position: Q3 2022 in Review

First Hawaiian Bank sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 7,705 shares — an estimated $239K sold.

First Hawaiian Bank first reported a position in EBS in Q3 2018 and held it in 16 quarters. The position peaked at $1.13M in Q3 2020. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

First Hawaiian Bank reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
First Hawaiian Bank sold 7,705 Emergent Biosolutions shares in Q3 2022, an estimated $239K.
First Hawaiian Bank first reported a position in Emergent Biosolutions in Q3 2018 and held it in 16 quarters.
First Hawaiian Bank's Emergent Biosolutions position peaked at $1.13M in Q3 2020.
211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on First Hawaiian Bank's 13F filing for Q3 2022, filed 5 Oct 2022.